Trial · NCT07882576
A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma
NCT07882576, Not yet recruiting, AstraZeneca
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma. Trials, record NCT07882576. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882576
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma
- NCT number
- NCT07882576
- Status
- Not yet recruiting
- Enrollment
- 532 participants, estimated
- Lead sponsor
- AstraZeneca
- Conditions
- Lymphoma, B-Cell
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Real-world progression-free survival (rwPFS), measured from the start of first-line (1L) treatment until clinically documented disease progression or death, with censoring at the time of the last contact. | through study completation, an avarege 1 year | Probability of survival at 2 years derived from the Kaplan-Meier analysis of real-world rwPFS (2- year rwPFS) |
| Secondary | Distribution of first-line (1L) treatment regimens | through study completation, an avarege 1 year | It will be summarized using descriptive statistics and Kaplan-Meier methods. |
| Secondary | Safety outcomes include hematologic and non-hematologic adverse events. | through study completation, an avarege 1 year | Safety will be assessed using adverse events that occurred during first-line treatment, with 95% confidence intervals. |
| Secondary | Distribution of treatment patterns | through study completation, an avarege 1 year | It will be summarized using descriptive statistics and Kaplan-Meier methods |
| Secondary | Distribution of overall survival | through study completation, an avarege 1 year | It will be summarized using descriptive statistics and Kaplan-Meier methods |
| Secondary | Treatment time to next treatment or death | through study completation, an avarege 1 year | It will be summarized using descriptive statistics and Kaplan-Meier methods |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882576
GET https://conductscience.org/api/trials/v1/NCT07882576/registered